Drug Shortage Report for COTAZYM
Report ID | 170162 |
Drug Identification Number | 00263818 |
Brand name | COTAZYM |
Common or Proper name | PANCRELIPASE CAPSULES |
Company Name | ORGANON CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | PROTEASE AMYLASE LIPASE |
Strength(s) | 35000UNIT 40000UNIT 10000UNIT |
Dosage form(s) | CAPSULE (IMMEDIATE RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A09AA |
ATC description | DIGESTIVES, INCL ENZYMES |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-09-23 |
Estimated end date | 2022-10-07 |
Actual end date | 2022-09-30 |
Shortage status | Resolved |
Updated date | 2022-10-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16766 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-844-820-5468 dpoc.canada@organon.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-10-01 | English | Compare |
v5 | 2022-09-30 | French | Compare |
v4 | 2022-09-30 | English | Compare |
v3 | 2022-09-24 | English | Compare |
v2 | 2022-09-23 | French | Compare |
v1 | 2022-09-23 | English | Compare |
Showing 1 to 6 of 6